DK0652871T3 - Absorberende artikel med fastgøringssystem, der tilvejebringer dynamisk tilpasning af elasticeret linning - Google Patents
Absorberende artikel med fastgøringssystem, der tilvejebringer dynamisk tilpasning af elasticeret linningInfo
- Publication number
- DK0652871T3 DK0652871T3 DK93917939T DK93917939T DK0652871T3 DK 0652871 T3 DK0652871 T3 DK 0652871T3 DK 93917939 T DK93917939 T DK 93917939T DK 93917939 T DK93917939 T DK 93917939T DK 0652871 T3 DK0652871 T3 DK 0652871T3
- Authority
- DK
- Denmark
- Prior art keywords
- 6alkyl
- optionally substituted
- pct
- azacyclic
- absorbent article
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/24—Camphidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929216123A GB9216123D0 (en) | 1992-07-29 | 1992-07-29 | Therapeutic agents |
GB929216231A GB9216231D0 (en) | 1992-07-30 | 1992-07-30 | Therapeutic agents |
GB929216238A GB9216238D0 (en) | 1992-07-30 | 1992-07-30 | Therapeutic agents |
GB929220957A GB9220957D0 (en) | 1992-10-06 | 1992-10-06 | Therapeutic agents |
GB929222821A GB9222821D0 (en) | 1992-10-30 | 1992-10-30 | Therapeutic agents |
GB929222934A GB9222934D0 (en) | 1992-11-02 | 1992-11-02 | Therapeutic compounds |
GB929223583A GB9223583D0 (en) | 1992-11-11 | 1992-11-11 | Therapeutic agents |
GB929226242A GB9226242D0 (en) | 1992-12-16 | 1992-12-16 | Therapeutic agents |
GB929226360A GB9226360D0 (en) | 1992-12-17 | 1992-12-17 | Therapeutic agents |
GB939301277A GB9301277D0 (en) | 1993-01-22 | 1993-01-22 | Therapeutic agents |
GB939307318A GB9307318D0 (en) | 1993-04-07 | 1993-04-07 | Therapeutic agents |
PCT/GB1993/001599 WO1994003437A1 (en) | 1992-07-29 | 1993-07-28 | Benzodiazepine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0652871T3 true DK0652871T3 (da) | 2001-12-03 |
Family
ID=27581673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93917939T DK0652871T3 (da) | 1992-07-29 | 1993-07-28 | Absorberende artikel med fastgøringssystem, der tilvejebringer dynamisk tilpasning af elasticeret linning |
Country Status (13)
Country | Link |
---|---|
US (1) | US5618812A (da) |
EP (1) | EP0652871B1 (da) |
JP (1) | JP3457312B2 (da) |
AT (1) | ATE207064T1 (da) |
AU (1) | AU671477B2 (da) |
CA (1) | CA2140009A1 (da) |
DE (1) | DE69330959T2 (da) |
DK (1) | DK0652871T3 (da) |
ES (1) | ES2163410T3 (da) |
GR (1) | GR3036924T3 (da) |
LV (1) | LV12956B (da) |
PT (1) | PT652871E (da) |
WO (1) | WO1994003437A1 (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08505120A (ja) * | 1992-07-29 | 1996-06-04 | メルク シヤープ エンド ドーム リミテツド | ベンゾジアゼピン誘導体 |
US5739129A (en) * | 1994-04-14 | 1998-04-14 | Glaxo Wellcome Inc. | CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines |
DE69637211T2 (de) | 1995-12-11 | 2008-05-08 | New England Medical Center Hospitals, Inc., Boston | Test für und verwendungen von liganden von peptidhormonrezeptoren. |
US5750353A (en) * | 1995-12-11 | 1998-05-12 | New England Medical Center Hospitals, Inc. | Assay for non-peptide agonists to peptide hormone receptors |
US5852010A (en) * | 1996-04-03 | 1998-12-22 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
AU3591697A (en) * | 1996-07-02 | 1998-01-21 | Merck & Co., Inc. | Method for the treatment of preterm labor |
US5929071A (en) * | 1996-07-02 | 1999-07-27 | Merck & Co., Inc. | Method for the treatment of preterm labor |
US6100254A (en) * | 1997-10-10 | 2000-08-08 | Board Of Regents, The University Of Texas System | Inhibitors of protein tyrosine kinases |
US6569851B1 (en) | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
NZ525513A (en) | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
WO2000038618A2 (en) | 1998-12-24 | 2000-07-06 | Du Pont Pharmaceuticals Company | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
US6503902B2 (en) | 1999-09-13 | 2003-01-07 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production |
US6960576B2 (en) * | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
CA2387493A1 (en) | 1999-10-08 | 2001-04-19 | Lorin Andrew Thompson | Amino lactam sulfonamides as inhibitors of a.beta. protein production |
NZ518037A (en) | 1999-10-15 | 2004-04-30 | F | Benzodiazepine derivatives useful as metabotropic glutamate receptors |
WO2001060826A2 (en) | 2000-02-17 | 2001-08-23 | Bristol-Myers Squibb Pharma Company | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
MXPA02009729A (es) | 2000-04-03 | 2003-03-27 | Bristol Myers Squibb Pharma Co | Lactamas ciclicas como inhibidores de la produccion de la proteina a-beta. |
BR0107532A (pt) | 2000-04-03 | 2004-11-03 | Bristol Myers Squibb Pharma Co | Composto, uso do composto, método para o tratamento de disfunções neurológicas associadas com a produção de b-amilóide, método de inibição da atividade de y-secretase e composição farmacêutica |
AU2001257006A1 (en) | 2000-04-11 | 2001-10-23 | Du Pont Pharmaceuticals Company | Substituted lactams as inhibitors of abeta protein production |
US20100009966A1 (en) * | 2001-04-11 | 2010-01-14 | Bristol-Myers Squibb Pharma Company | Substituted lactams as inhibitors of abeta protein production |
US6878363B2 (en) * | 2000-05-17 | 2005-04-12 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
BR0106717A (pt) | 2000-06-01 | 2002-04-16 | Bristol Myers Squibb Pharma Co | Compostos, composição farmacêutica e usos dos compostos de lactama inovadora |
EP1383792A2 (en) * | 2000-08-22 | 2004-01-28 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Sh2 domain binding inhibitors |
US20090062256A1 (en) * | 2001-06-01 | 2009-03-05 | Bristol-Myers Squibb Pharma Company | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
US6974869B2 (en) * | 2001-09-18 | 2005-12-13 | Bristol-Myers Squibb Pharma Company | Piperizinones as modulators of chemokine receptor activity |
DE10163595A1 (de) * | 2001-12-21 | 2003-08-07 | Gruenenthal Gmbh | In 3-Position heterocyclisch substituierte Piperidin-2,6-dione |
US7845356B2 (en) * | 2002-09-06 | 2010-12-07 | Koninklijke Philips Electronics N.V. | Implantable devices, systems, and methods for maintaining desired orientations in targeted tissue regions |
US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
KR101155335B1 (ko) * | 2005-01-07 | 2012-06-11 | 엘지전자 주식회사 | 이동통신 단말기의 멀티미디어 메시지 동작방법 |
US7781503B2 (en) * | 2005-12-29 | 2010-08-24 | Firestone Polymers, Llc | Modified asphalt binders and asphalt paving compositions |
US7642302B2 (en) * | 2005-12-29 | 2010-01-05 | Firestone Polymers, Llc | Modified asphalt binders and asphalt paving compositions |
BRPI0810655A2 (pt) | 2007-04-19 | 2014-11-04 | Hoffmann La Roche | Derivados de di-hidro-benzo[b][1,4] diazepin-2-ona sulfonamida |
EP2146722A4 (en) * | 2007-05-10 | 2011-08-03 | Amr Technology Inc | ARYL AND HETEROARYL SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND THEIR USE FOR BLOCKING THE RECOVERY OF NOREPINEPHRIN, DOPAMINE AND SEROTONINE |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL96613A0 (en) * | 1989-12-18 | 1991-09-16 | Merck & Co Inc | Pharmaceutical compositions containing benzodiazepine analogs |
CA2032226A1 (en) * | 1989-12-18 | 1991-06-19 | Mark G. Bock | Benzodiazepine analogs |
EP0539170A1 (en) * | 1991-10-24 | 1993-04-28 | Merck Sharp & Dohme Ltd. | Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors |
EP0545478A1 (en) * | 1991-12-03 | 1993-06-09 | MERCK SHARP & DOHME LTD. | Heterocyclic compounds as tachykinin antagonists |
EP0617621A4 (en) * | 1991-12-20 | 1995-04-05 | Merck Sharp & Dohme | CENTRAL CHOLECYSTOKININ ANTAGONISTS HAVING PHARMACEUTICAL EFFECTIVENESS. |
GB9209518D0 (en) * | 1992-05-01 | 1992-06-17 | Merck Sharp & Dohme | Therapeutic agents |
US5360802A (en) * | 1992-05-11 | 1994-11-01 | Merck Sharpe & Dohme Ltd. | Benzodiazepine derivatives, compositions containing them and their use in therapy |
JPH08505120A (ja) * | 1992-07-29 | 1996-06-04 | メルク シヤープ エンド ドーム リミテツド | ベンゾジアゼピン誘導体 |
-
1993
- 1993-07-28 DK DK93917939T patent/DK0652871T3/da active
- 1993-07-28 DE DE69330959T patent/DE69330959T2/de not_active Expired - Fee Related
- 1993-07-28 AU AU47178/93A patent/AU671477B2/en not_active Ceased
- 1993-07-28 WO PCT/GB1993/001599 patent/WO1994003437A1/en active IP Right Grant
- 1993-07-28 CA CA002140009A patent/CA2140009A1/en not_active Abandoned
- 1993-07-28 JP JP50508994A patent/JP3457312B2/ja not_active Expired - Fee Related
- 1993-07-28 AT AT93917939T patent/ATE207064T1/de not_active IP Right Cessation
- 1993-07-28 ES ES93917939T patent/ES2163410T3/es not_active Expired - Lifetime
- 1993-07-28 EP EP93917939A patent/EP0652871B1/en not_active Expired - Lifetime
- 1993-07-28 US US08/374,748 patent/US5618812A/en not_active Expired - Fee Related
- 1993-07-28 PT PT93917939T patent/PT652871E/pt unknown
-
2001
- 2001-10-18 GR GR20010401745T patent/GR3036924T3/el not_active IP Right Cessation
-
2002
- 2002-10-16 LV LVP-02-185A patent/LV12956B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP3457312B2 (ja) | 2003-10-14 |
AU671477B2 (en) | 1996-08-29 |
GR3036924T3 (en) | 2002-01-31 |
EP0652871B1 (en) | 2001-10-17 |
DE69330959T2 (de) | 2002-04-11 |
ES2163410T3 (es) | 2002-02-01 |
ATE207064T1 (de) | 2001-11-15 |
EP0652871A1 (en) | 1995-05-17 |
DE69330959D1 (de) | 2001-11-22 |
CA2140009A1 (en) | 1994-02-17 |
JPH07509482A (ja) | 1995-10-19 |
PT652871E (pt) | 2002-03-28 |
LV12956B (en) | 2003-06-20 |
WO1994003437A1 (en) | 1994-02-17 |
US5618812A (en) | 1997-04-08 |
AU4717893A (en) | 1994-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0652871T3 (da) | Absorberende artikel med fastgøringssystem, der tilvejebringer dynamisk tilpasning af elasticeret linning | |
ATE204269T1 (de) | Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
YU47969B (sh) | Postupak za dobijanje derivata pirimidinona kao kalcijum nezavisnih camp inhibitora fosfordiesteraze | |
ES2141174T3 (es) | 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina. | |
ES2188280T3 (es) | Acetales heteroaril-ciclicos. | |
DE69324001T2 (de) | Benzocycloheptine, benzoxepine und benzothiepine | |
TW333532B (en) | Benzopyrans | |
DE69318920D1 (de) | Ellipticinderivate mit Antitumorwirkung | |
MY131762A (en) | Pharmaceutical compounds | |
DK0561863T3 (da) | Amidiske derivater af glutamin-, asparagin- og 2-aminoadipinsyrer med antigastrin-virkning | |
FI963130A0 (fi) | Heterosykliset yhdisteet sekä niiden valmistus ja käyttö | |
PT84161A (pt) | Procede de preparation de derives d:acylaminomethyl-3 imidazo ]1,2-a" pyridines et de compositions pharmaceutiques les contenant | |
ES2082461T3 (es) | Compuesto anticanceroso. | |
UA41348C2 (uk) | Проліки 3-ацил-2-оксіндол-1-карбоксамідів та фармацевтична композиція | |
DE69403896T2 (de) | 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten | |
DK0877612T3 (da) | Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser | |
ES2101269T3 (es) | Nuevos derivados de 1-fenil-biciclo-(2.2.2)-octano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
DE69414117D1 (de) | 1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten | |
ES8606355A1 (es) | Un procedimiento para la preparacion de derivados de imida- zodiacepina |